STAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more

People on Medicare are not getting recently approved Alzheimer's medications as much as anticipated, and uptake for the drugs has been muted. Meanwhile, there is a shortage of estrogen patches, with doctors and patients reporting difficulties in getting certain doses. The U.S. Food and Drug Administration has not yet included any estrogen patches on its list of drug shortages.